EP1.01-96 Metastatic Lymphoepithelial Lung Cancer

Lung & Metastatic Cancer Mimics

Relationship between the expression of miR137 in the serum of patients with metastatic lung cancer

Background: Micro-Ribonocellic Acids (miRNA) are non-coding nucleic acids that are evolutionally protected and have a length of 24-20 nucleotides. MiRNAs control the expression of genes after transcription by mRNA degradation or translation inhibition. By blocking the oncogenic miRNAs and creating the necessary and functional miRNAs (tumor suppressor), these small regulatory RNAs can have thera...

386-389 Metastatic Lung Cancer

Ablation for metastatic lung cancer

Since first report of RFA in lung tumor in year 2000, RFA has been demonstrated to provide 80 to 90% complete ablation for tumors less than 2 cm, with decrease in efficacy for larger tumors. Percutaneous ablation is today a valid option for lung metastases in non surgical candidates with overall survival reported after RFA is in between 56 to 67% at 3 years. Such survival reported is comparable...

Metastatic sites and survival in lung cancer.

OBJECTIVES Population-based data on metastatic sites and survival in site-specific metastases are lacking for lung cancer and for any cancer because most cancer registries do not record metastases. This study uses a novel population-based approach to identify metastases from both death certificates and national inpatient data to describe metastatic pathways in lung cancer patients. MATERIALS ...